Gadgets Neurocentrx Closes Seed Extension Round Including Funding from the Wellcome TrustHealthradar25. September 2025 Will Provide Funding for Clinical Trials of Neurocentrx’s Novel Ketamine Prescription Option for Clinic-to-Home Based CareWellcome Investment for a Phase…
